GLP-1 receptor agonists are reshaping obesity care. OHE highlights access challenges, prescribing policy, and how patient and ...

Dimitrios is an economist and his research interests lie in the fields of the economics of innovation and specifically on the economics of pharmaceutical markets and R&D. In addition, he is interested ...

An OHE report analyses the rise in NICE’s optimised decisions from 2025 to 2024 and how they affect patient access, HTA ...

Long-acting therapies offer value for chronic disease, improving adherence and outcomes. This OHE report highlights HTA gaps, ...

Laura Vallejo-Torres is Associate Professor at the University of Las Palmas de Gran Canaria, Spain. She holds an MSc in Health Economics from the University of York and a Ph.D. in Health Economics ...

Kelsey joined OHE in March 2025 as an External Engagement Officer. She holds a BA degree in Psychology from the University of Chicago and an MSc Public Health (Health Promotion) from the London School ...

Immunisation programmes are foundational to public health. Organised by health authorities, they systematically deliver vaccines to susceptible populations to prevent the spread of infectious diseases ...